Glioblastoma Tumors with Decelerated Epigenetic Aging Are Characterized by Glutamatergic Neuronal Activity and Stemness
Meysam Motevasseli, Majid Eterafi, Hananeh Alaei, Pouyan Zandi, Neda Shajari, Mina Hajifaraj Tabrizi, Elham Safarzadeh
This study identifies decelerated epigenetic aging in glioblastoma tumors linked to glutamatergic neuronal activity and stemness, showing that anti-glutamatergic drugs enhance temozolomide's effectiveness.
bioRxiv · Aug 31, 2026 · PreprintCancer Biology